MTD of palbociclib isethionate defined as the highest dose level at which six patients have been treated with at most one patient experiencing a dose limiting toxicity and the next higher dose level has been determined to be too toxic 4 weeks [clinicaltrials_resource:ae6accf221a225b1e2e51153edf0e99e]
Will be graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 4.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
MTD of palbociclib isethionate defined as the highest dose level at which six patients have been treated with at most one patient experiencing a dose limiting toxicity and the next higher dose level has been determined to be too toxic 4 weeks [clinicaltrials_resource:ae6accf221a225b1e2e51153edf0e99e]
Will be graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 4.
Bio2RDF identifier
ae6accf221a225b1e2e51153edf0e99e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ae6accf221a225b1e2e51153edf0e99e
measure [clinicaltrials_vocabulary:measure]
MTD of palbociclib isethionate ...... een determined to be too toxic
time frame [clinicaltrials_vocabulary:time-frame]
description
Will be graded according to th ...... for Adverse Events version 4.
identifier
clinicaltrials_resource:ae6accf221a225b1e2e51153edf0e99e
title
MTD of palbociclib isethionate ...... rmined to be too toxic 4 weeks
@en
type
label
MTD of palbociclib isethionate ...... accf221a225b1e2e51153edf0e99e]
@en